Skull base manifestations of Camurati-Engelmann disease

Matthew L. Carlson, Charles W. Beatty, Brian A. Neff, Michael J. Link, Colin L.W. Driscoll

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: To describe presenting symptoms, evaluation findings, and surgical management of cranial base hyperostosis in patients with Camurati-Engelmann disease (CED). Design: Retrospective study and literature review. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: A total of 306 patients diagnosed as having CED, including 12 primarily evaluated at our institution between 1968 and 2008, and 294 identified in the international literature. Main Outcome Measures: Presenting symptoms, methods of diagnosis, treatment strategies, and patient outcomes. Results: One hundred seventy-three of 306 patients (56.5%) had radiographically proven skull base hyperostosis, whereas less than one-fourth were symptomatic. The most common manifestations of cranial base involvement were hearing loss (19.0%), headache (10.4%), exophthalmos (8.2%), and frontal bossing (7.2%); less common were vision changes, vertigo, facial weakness, symptomatic brainstem compression, facial numbness, and hyposmia. Although corticosteroids and bisphosphates may treat torso and extremity involvement, they demonstrate no benefit for symptomatic skull base disease. In select symptomatic patients, aggressive decompression surgery may provide the only means of treatment. Decompression surgery is more challenging with thick sclerotic bone, loss or obscuration of bony landmarks, and decreased supratentorial space. Patients must be counseled on the increased risks associated with surgery and the potential for redeposition of bone and recurrence of symptoms. Conclusions: Physicians should include CED in the differential diagnosis for patients with radiographic evidence of skull base thickening and synchronous cranial neuropathies or symptoms of elevated intracranial pressure. In mild forms of the disease, the clinical course of patients should be followed with serial examination, audiometric testing, and radiography. In select patients with progressive cranial base symptoms, aggressive wide decompression of involved neurovascular structures may provide benefit.

Original languageEnglish (US)
Pages (from-to)566-575
Number of pages10
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume136
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Camurati-Engelmann Syndrome
Skull Base
Decompression
Hyperostosis
Cranial Nerve Diseases
Bone and Bones
Torso
Exophthalmos
Intracranial Hypertension
Symptom Assessment
Hypesthesia
Vertigo
Hearing Loss
Radiography
Brain Stem
Headache

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology
  • Medicine(all)

Cite this

Carlson, M. L., Beatty, C. W., Neff, B. A., Link, M. J., & Driscoll, C. L. W. (2010). Skull base manifestations of Camurati-Engelmann disease. Archives of Otolaryngology - Head and Neck Surgery, 136(6), 566-575. https://doi.org/10.1001/archoto.2010.68

Skull base manifestations of Camurati-Engelmann disease. / Carlson, Matthew L.; Beatty, Charles W.; Neff, Brian A.; Link, Michael J.; Driscoll, Colin L.W.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 136, No. 6, 06.2010, p. 566-575.

Research output: Contribution to journalArticle

Carlson, ML, Beatty, CW, Neff, BA, Link, MJ & Driscoll, CLW 2010, 'Skull base manifestations of Camurati-Engelmann disease', Archives of Otolaryngology - Head and Neck Surgery, vol. 136, no. 6, pp. 566-575. https://doi.org/10.1001/archoto.2010.68
Carlson, Matthew L. ; Beatty, Charles W. ; Neff, Brian A. ; Link, Michael J. ; Driscoll, Colin L.W. / Skull base manifestations of Camurati-Engelmann disease. In: Archives of Otolaryngology - Head and Neck Surgery. 2010 ; Vol. 136, No. 6. pp. 566-575.
@article{d599fa6c2e8b4033950c363df1c80fd4,
title = "Skull base manifestations of Camurati-Engelmann disease",
abstract = "Objective: To describe presenting symptoms, evaluation findings, and surgical management of cranial base hyperostosis in patients with Camurati-Engelmann disease (CED). Design: Retrospective study and literature review. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: A total of 306 patients diagnosed as having CED, including 12 primarily evaluated at our institution between 1968 and 2008, and 294 identified in the international literature. Main Outcome Measures: Presenting symptoms, methods of diagnosis, treatment strategies, and patient outcomes. Results: One hundred seventy-three of 306 patients (56.5{\%}) had radiographically proven skull base hyperostosis, whereas less than one-fourth were symptomatic. The most common manifestations of cranial base involvement were hearing loss (19.0{\%}), headache (10.4{\%}), exophthalmos (8.2{\%}), and frontal bossing (7.2{\%}); less common were vision changes, vertigo, facial weakness, symptomatic brainstem compression, facial numbness, and hyposmia. Although corticosteroids and bisphosphates may treat torso and extremity involvement, they demonstrate no benefit for symptomatic skull base disease. In select symptomatic patients, aggressive decompression surgery may provide the only means of treatment. Decompression surgery is more challenging with thick sclerotic bone, loss or obscuration of bony landmarks, and decreased supratentorial space. Patients must be counseled on the increased risks associated with surgery and the potential for redeposition of bone and recurrence of symptoms. Conclusions: Physicians should include CED in the differential diagnosis for patients with radiographic evidence of skull base thickening and synchronous cranial neuropathies or symptoms of elevated intracranial pressure. In mild forms of the disease, the clinical course of patients should be followed with serial examination, audiometric testing, and radiography. In select patients with progressive cranial base symptoms, aggressive wide decompression of involved neurovascular structures may provide benefit.",
author = "Carlson, {Matthew L.} and Beatty, {Charles W.} and Neff, {Brian A.} and Link, {Michael J.} and Driscoll, {Colin L.W.}",
year = "2010",
month = "6",
doi = "10.1001/archoto.2010.68",
language = "English (US)",
volume = "136",
pages = "566--575",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Skull base manifestations of Camurati-Engelmann disease

AU - Carlson, Matthew L.

AU - Beatty, Charles W.

AU - Neff, Brian A.

AU - Link, Michael J.

AU - Driscoll, Colin L.W.

PY - 2010/6

Y1 - 2010/6

N2 - Objective: To describe presenting symptoms, evaluation findings, and surgical management of cranial base hyperostosis in patients with Camurati-Engelmann disease (CED). Design: Retrospective study and literature review. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: A total of 306 patients diagnosed as having CED, including 12 primarily evaluated at our institution between 1968 and 2008, and 294 identified in the international literature. Main Outcome Measures: Presenting symptoms, methods of diagnosis, treatment strategies, and patient outcomes. Results: One hundred seventy-three of 306 patients (56.5%) had radiographically proven skull base hyperostosis, whereas less than one-fourth were symptomatic. The most common manifestations of cranial base involvement were hearing loss (19.0%), headache (10.4%), exophthalmos (8.2%), and frontal bossing (7.2%); less common were vision changes, vertigo, facial weakness, symptomatic brainstem compression, facial numbness, and hyposmia. Although corticosteroids and bisphosphates may treat torso and extremity involvement, they demonstrate no benefit for symptomatic skull base disease. In select symptomatic patients, aggressive decompression surgery may provide the only means of treatment. Decompression surgery is more challenging with thick sclerotic bone, loss or obscuration of bony landmarks, and decreased supratentorial space. Patients must be counseled on the increased risks associated with surgery and the potential for redeposition of bone and recurrence of symptoms. Conclusions: Physicians should include CED in the differential diagnosis for patients with radiographic evidence of skull base thickening and synchronous cranial neuropathies or symptoms of elevated intracranial pressure. In mild forms of the disease, the clinical course of patients should be followed with serial examination, audiometric testing, and radiography. In select patients with progressive cranial base symptoms, aggressive wide decompression of involved neurovascular structures may provide benefit.

AB - Objective: To describe presenting symptoms, evaluation findings, and surgical management of cranial base hyperostosis in patients with Camurati-Engelmann disease (CED). Design: Retrospective study and literature review. Setting: The Mayo Clinic, Rochester, Minnesota. Patients: A total of 306 patients diagnosed as having CED, including 12 primarily evaluated at our institution between 1968 and 2008, and 294 identified in the international literature. Main Outcome Measures: Presenting symptoms, methods of diagnosis, treatment strategies, and patient outcomes. Results: One hundred seventy-three of 306 patients (56.5%) had radiographically proven skull base hyperostosis, whereas less than one-fourth were symptomatic. The most common manifestations of cranial base involvement were hearing loss (19.0%), headache (10.4%), exophthalmos (8.2%), and frontal bossing (7.2%); less common were vision changes, vertigo, facial weakness, symptomatic brainstem compression, facial numbness, and hyposmia. Although corticosteroids and bisphosphates may treat torso and extremity involvement, they demonstrate no benefit for symptomatic skull base disease. In select symptomatic patients, aggressive decompression surgery may provide the only means of treatment. Decompression surgery is more challenging with thick sclerotic bone, loss or obscuration of bony landmarks, and decreased supratentorial space. Patients must be counseled on the increased risks associated with surgery and the potential for redeposition of bone and recurrence of symptoms. Conclusions: Physicians should include CED in the differential diagnosis for patients with radiographic evidence of skull base thickening and synchronous cranial neuropathies or symptoms of elevated intracranial pressure. In mild forms of the disease, the clinical course of patients should be followed with serial examination, audiometric testing, and radiography. In select patients with progressive cranial base symptoms, aggressive wide decompression of involved neurovascular structures may provide benefit.

UR - http://www.scopus.com/inward/record.url?scp=77953892142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953892142&partnerID=8YFLogxK

U2 - 10.1001/archoto.2010.68

DO - 10.1001/archoto.2010.68

M3 - Article

C2 - 20566907

AN - SCOPUS:77953892142

VL - 136

SP - 566

EP - 575

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 6

ER -